Cellromax Science Co., Ltd. (471820.KQ)
KOSDAQ · KRW · Healthcare · Pharmaceutical Retailers
₩4,050 (+0.00%) as of
Key statistics
- Market cap
- 44.53B
- Dividend yield
- 4.94%
- 52-week range
- 0.00 – 7,690.00
- Revenue (TTM)
- 19.6B
- Profit margin
- 15.65%
About Cellromax Science Co., Ltd.
Cellromax Science Co., Ltd. focuses to merge with other companies. The company was founded in 2022 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Seoul, South Korea
- Employees
- 43
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.